AU Patent

AU2009345790B2 — Topical solution formulations containing a corticosteroid and a cyclodextrin

Assigned to Novartis AG · Expires 2012-07-05 · 14y expired

What this patent protects

Solution formulations containing a corticosteroid, cyclodextrin, and xanthan gum are disclosed. The formulations are intended for topical application to the eye, ear, or nose.

USPTO Abstract

Solution formulations containing a corticosteroid, cyclodextrin, and xanthan gum are disclosed. The formulations are intended for topical application to the eye, ear, or nose.

Drugs covered by this patent

Patent Metadata

Patent number
AU2009345790B2
Jurisdiction
AU
Classification
—
Expires
2012-07-05
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.